Literature DB >> 9034160

Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.

R M Weinshilboum1, D M Otterness, I A Aksoy, T C Wood, C Her, R B Raftogianis.   

Abstract

Sulfotransferase (ST) enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These reactions result in enhanced renal excretion of the sulfate-conjugated reaction products, but they can also lead to the formation of "bioactivated" metabolites. ST enzymes are members of an emerging gene superfamily that presently includes phenol ST (PST), hydroxysteroid ST (HSST), and, in plants, flavonol ST (FST) "families," members of which share at least 45% amino acid sequence identity. These families can be further subdivided into "subfamilies" that are at least 60% identical in amino acid sequence. For example, the PST family includes both PST and estrogen ST (EST) subfamilies. Amino acid sequence motifs exist within ST enzymes that are conserved throughout phylogeny. These signature sequences may be involved in the binding of 3'-phosphoadenosine-5 '-phosphosulfate, the cosubstrate for the sulfonation reaction. There are presently five known human cytosolic ST enzymes: an EST, an HSST, and three PSTs. cDNAs and genes for all of these enzymes have been cloned, and chromosomal localizations have been reported for all five genes. Genes for these human enzymes, as well as those of other mammalian cytosolic ST enzymes that have been cloned, show a high degree of structural homology, with conservation of the locations of most intron/exon splice junctions. Human ST enzyme expression varies among individuals. Functionally significant genetic polymorphisms for ST enzymes in humans have been reported, and other molecular genetic mechanisms that might be involved in the regulation of the expression of these enzymes are being explored. Knowledge of the molecular biology of cytosolic ST enzymes, when placed within a context provided by decades of biochemical research, promises to significantly enhance our understanding of the regulation of the sulfate conjugation of hormones, neurotransmitters, and drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034160

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  80 in total

1.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

3.  The human estrogen sulfotransferase: a half-site reactive enzyme.

Authors:  Meihao Sun; Thomas S Leyh
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

4.  Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

Authors:  Lin Yi; Joe Dratter; Chao Wang; Jon A Tunge; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2006-05-25       Impact factor: 4.142

5.  Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain.

Authors:  Emily D Salman; Susan A Kadlubar; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

6.  The inhibitory effect of bamboo extract on the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer.

Authors:  Yanling Lin; Abby C Collier; Wanyu Liu; Marla J Berry; Jun Panee
Journal:  Phytother Res       Date:  2008-11       Impact factor: 5.878

7.  Metabolic enzyme considerations in cancer therapy.

Authors:  Amit K Jain; Sweta Jain; A C Rana
Journal:  Malays J Med Sci       Date:  2007-01

8.  Monoamine neurotransmitters as substrates for novel tick sulfotransferases, homology modeling, molecular docking, and enzyme kinetics.

Authors:  Emine Bihter Yalcin; Hubert Stangl; Sivakamasundari Pichu; Thomas N Mather; Roberta S King
Journal:  ACS Chem Biol       Date:  2010-11-15       Impact factor: 5.100

9.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

Review 10.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.